<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Atrial Fibrillation Blog&#187; Medication</title>
	<atom:link href="http://atrialfibrillationblog.com/category/medication/feed/" rel="self" type="application/rss+xml" />
	<link>http://atrialfibrillationblog.com</link>
	<description>From StopAfib.org - For Afib Patients, By Afib Patients</description>
	<lastBuildDate>Fri, 03 Feb 2012 07:55:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Update on Atrial Fibrillation Stroke Prevention — Video interview with Dr. Daniel Singer of Harvard</title>
		<link>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/</link>
		<comments>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 13:11:20 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Resources]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[anticoagulants]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[Dr Daniel Singer]]></category>
		<category><![CDATA[edoxaban]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[video]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1223</guid>
		<description><![CDATA[In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/update-on-atrial-fibrillation-stroke-prevention-video-interview-with-dr-daniel-singer-of-harvard/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boston Atrial Fibrillation Symposium 2012 Recap and Notes – Guest Posts by Dr. John Mandrola</title>
		<link>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/</link>
		<comments>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 18:13:43 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Sleep Apnea]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[focal beats]]></category>
		<category><![CDATA[pulmonary vein isolation]]></category>
		<category><![CDATA[reconnection]]></category>
		<category><![CDATA[rotors]]></category>
		<category><![CDATA[surgical ablation]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1176</guid>
		<description><![CDATA[Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/boston-atrial-fibrillation-symposium-2012-recap-and-notes-guest-posts-by-dr-john-mandrola/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Stuck in the Middle: Afib Patients on Rate Control, from EP Lab Digest January, 2012</title>
		<link>http://atrialfibrillationblog.com/stuck-in-the-middle-afib-patients-on-rate-control-from-ep-lab-digest-january-2012/</link>
		<comments>http://atrialfibrillationblog.com/stuck-in-the-middle-afib-patients-on-rate-control-from-ep-lab-digest-january-2012/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 19:27:12 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[AV Node Ablation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Symptoms]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Women]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[beta blocker]]></category>
		<category><![CDATA[EP Lab Digest]]></category>
		<category><![CDATA[heart failure]]></category>
		<category><![CDATA[Mellanie True Hills]]></category>
		<category><![CDATA[quality of life]]></category>
		<category><![CDATA[rate control medication]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[symptoms]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1145</guid>
		<description><![CDATA[Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/stuck-in-the-middle-afib-patients-on-rate-control-from-ep-lab-digest-january-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top Atrial Fibrillation (Afib) Articles of 2011</title>
		<link>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-articles-of-2011/</link>
		<comments>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-articles-of-2011/#comments</comments>
		<pubDate>Thu, 29 Dec 2011 22:12:42 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Sleep Apnea]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke prevention]]></category>
		<category><![CDATA[anticoagulant]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[hybrid ablation]]></category>
		<category><![CDATA[maze procedure]]></category>
		<category><![CDATA[Multaq]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1134</guid>
		<description><![CDATA[In follow up to our announcement yesterday of the Top Ten Atrial Fibrillation Videos of 2011, StopAfib.org now unveils the Top Ten Atrial Fibrillation Articles of 2011. Major topics of interest to the atrial fibrillation patient community this year were afib stroke prevention and the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-articles-of-2011/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Top Atrial Fibrillation (Afib) Videos of 2011</title>
		<link>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-videos-of-2011/</link>
		<comments>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-videos-of-2011/#comments</comments>
		<pubDate>Wed, 28 Dec 2011 21:22:31 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Catheter ablation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Sleep Apnea]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib stroke prevention]]></category>
		<category><![CDATA[anticoagulant]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[dabigatran]]></category>
		<category><![CDATA[maze procedure]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[surgical ablation]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1127</guid>
		<description><![CDATA[StopAfib.org has announced the Top Ten Atrial Fibrillation Videos of 2011. Afib stroke prevention again topped the list, with stories about warfarin (Coumadin), alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto), and the CHADS2 and CHA2DS2-VASc scoring tools for determining whether anticoagulants are needed. Other popular topics included sleep apnea, catheter ablation, and maze procedures (surgical [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/top-atrial-fibrillation-afib-videos-of-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Apixaban (Eliquis) prevents more atrial fibrillation strokes than warfarin — March FDA approval expected</title>
		<link>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/</link>
		<comments>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 18:00:10 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[apixaban]]></category>
		<category><![CDATA[atrial fibrillation stroke prevention]]></category>
		<category><![CDATA[Eliquis]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=1100</guid>
		<description><![CDATA[A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/apixaban-eliquis-prevents-more-atrial-fibrillation-strokes-than-warfarin-%e2%80%94-march-fda-approval-expected/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Alternative to Warfarin — Rivaroxaban (Xarelto) Approved for Atrial Fibrillation Stroke Prevention</title>
		<link>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/</link>
		<comments>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/#comments</comments>
		<pubDate>Mon, 07 Nov 2011 13:08:52 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[warfarin]]></category>
		<category><![CDATA[Xarelto]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=920</guid>
		<description><![CDATA[The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/fda-approves-alternative-to-warfarin-%e2%80%94-rivaroxaban-xarelto-approved-for-atrial-fibrillation-stroke-prevention/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>CHA2DS2-VASc or CHADS2 For Atrial Fibrillation Stroke Prevention? Should Aspirin Be Used? Video with Prof. Greg Lip</title>
		<link>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/</link>
		<comments>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/#comments</comments>
		<pubDate>Mon, 24 Oct 2011 12:12:21 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Audio/Video]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[CHA2DS2-VASc]]></category>
		<category><![CDATA[CHADS2]]></category>
		<category><![CDATA[Gregory Y. H. Lip MD]]></category>
		<category><![CDATA[stroke prevention]]></category>
		<category><![CDATA[video]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=897</guid>
		<description><![CDATA[In this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk and why aspirin is not appropriate for preventing strokes. Watch the video at: Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation — Video]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/cha2ds2-vasc-or-chads2-for-atrial-fibrillation-stroke-prevention-should-aspirin-be-used-video-with-prof-greg-lip/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Breaking News: FDA Panel Recommends Approval of Rivaroxaban (Xarelto) for Atrial Fibrillation Stroke Prevention</title>
		<link>http://atrialfibrillationblog.com/breaking-news-fda-committee-votes-to-recommend-approval-of-rivaroxaban-xarelto-for-afib-stroke-prevention/</link>
		<comments>http://atrialfibrillationblog.com/breaking-news-fda-committee-votes-to-recommend-approval-of-rivaroxaban-xarelto-for-afib-stroke-prevention/#comments</comments>
		<pubDate>Thu, 08 Sep 2011 21:59:43 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[stroke risk]]></category>
		<category><![CDATA[warfarin]]></category>
		<category><![CDATA[Xarelto]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=868</guid>
		<description><![CDATA[The US Food &#38; Drug Administration (FDA) Advisory Committee just voted 9-2, with 1 abstaining, to recommend that the FDA approve rivaroxaban (Xarelto) for prevention of atrial fibrillation strokes. See our full story, now up at: FDA Panel Votes for Rivaroxaban: Atrial Fibrillation Patients May Soon Have Two Alternatives to Warfarin for Stroke Prevention]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/breaking-news-fda-committee-votes-to-recommend-approval-of-rivaroxaban-xarelto-for-afib-stroke-prevention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rivaroxaban (Xarelto) Effective for Atrial Fibrillation Patients with High Stroke Risk</title>
		<link>http://atrialfibrillationblog.com/rivaroxaban-xarelto-effective-for-atrial-fibrillation-patients-with-high-stroke-risk/</link>
		<comments>http://atrialfibrillationblog.com/rivaroxaban-xarelto-effective-for-atrial-fibrillation-patients-with-high-stroke-risk/#comments</comments>
		<pubDate>Tue, 06 Sep 2011 12:24:56 +0000</pubDate>
		<dc:creator>Mellanie</dc:creator>
				<category><![CDATA[Anticoagulation]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Study]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[afib strokes]]></category>
		<category><![CDATA[atrial fibrillation stroke risk]]></category>
		<category><![CDATA[coumadin]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[rivaroxaban]]></category>
		<category><![CDATA[ROCKET AF]]></category>
		<category><![CDATA[warfarin]]></category>
		<category><![CDATA[Xarelto]]></category>

		<guid isPermaLink="false">http://atrialfibrillationblog.com/?p=857</guid>
		<description><![CDATA[Just ahead of the FDA Advisory Committee hearing on rivaroxaban for stroke prevention in atrial fibrillation, we report in more depth on the ROCKET-AF trial results published recently in the New England Journal of Medicine. Rivaroxaban was shown to be as effective as warfarin (Coumadin) for stroke prevention in a high-risk afib population. To learn [...]]]></description>
		<wfw:commentRss>http://atrialfibrillationblog.com/rivaroxaban-xarelto-effective-for-atrial-fibrillation-patients-with-high-stroke-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced

Served from: atrialfibrillationblog.com @ 2012-02-07 16:47:47 -->
